Modern approach to the treatment of patients with CHD
Functional state of the liver on the background of hypolipidemic therapy in patients with ischaemic heart disease
- 84 Seiten
- 3 Lesestunden
Cardiovascular disease remains a major public health issue, primarily linked to high cholesterol levels, particularly low-density lipoprotein (LDL). Atherosclerosis arises from lipid metabolism abnormalities and vascular inflammation, with treatment strategies focusing on lowering LDL and boosting protective lipoproteins. Statins are highlighted as effective in reducing cholesterol and preventing cardiovascular issues. Additionally, milk thistle, containing the antioxidant silymarin, shows promise as a liver-protective agent, potentially aiding in the treatment of liver diseases like hepatitis and cirrhosis.
